A FAAH-regulated class of N-acyl taurines that activates TRP ion channels

Biochemistry

Volumn 45, Issue 30, 2006, Pages 9007-9015

  Saghatelian, Alan ^a   McKinney, Michele K ^a   Bandell, Michael ^a   Patapoutian, Ardem ^a   Cravatt, Benjamin F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; FATTY ACIDS; LIPIDS; METABOLISM; NITROGEN COMPOUNDS; TISSUE;

CHRONIC INACTIVATION; N-ACYL TAURINES (NATS); PHYSIOLOGICAL SUBSTRATES; TRANSIENT RECEPTOR POTENTIAL (TRP);

ENZYMES;

ANANDAMIDE; CALCIUM CHANNEL; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDE; FATTY ACID DERIVATIVE; N ACYLETHANOLAMINE; N ACYLTAURINE DERIVATIVE; N OLEOYLETHANOLAMINE; PALMIDROL; TAURINE DERIVATIVE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 4;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CATABOLISM; CENTRAL NERVOUS SYSTEM; ENZYME INACTIVATION; KIDNEY; LIPID METABOLISM; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AMIDOHYDROLASES; ANIMALS; BENZAMIDES; CARBAMATES; CHO CELLS; CRICETINAE; ENZYME INHIBITORS; MICE; MICE, KNOCKOUT; TAURINE; TISSUE DISTRIBUTION; TRPV CATION CHANNELS;

EID: 33746657575     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0608008     Document Type: Article

References (38)

1. Ishii, I., Fukushima, N., Ye, X., and Chun, J. (2004) Lysophospholipid receptors: signaling and biology, Annu. Rev. Biochem. 73, 321-354.
2. Di Marzo, V. (1998) Endocannabinoids and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance, Biochim. Biophys. Acta 1392, 153-175.
3. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258, 1946-1949.
4. Cravatt, B. F., Prospero-Garcia, O., Siuzdak, G., Gilula, N. B., Henriksen, S. J., Boger, D. L., and Lerner, R. A. (1995) Chemical characterization of a family of brain lipids that induce sleep, Science 268, 1506-1509.
5. Lambert, D. M., Vandevoorde, S., Jonsson, K. O., and Fowler, C. J. (2002) The palmitoylethanolamide family: a new class of anti-inflammatory agents?, Curr. Med. Chem. 9, 663-674.
6. Rodriguez de Fonseca, F., Navarro, M., Gomez, R., Escuredo, L., Nava, F., Fu, J., Murillo-Rodriguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., Kathuria, S., Gall, C., and Piomelli, D. (2001) An anorexic lipid mediator regulated by feeding, Nature 414, 209-212.
7. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., and Gilula, N. B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature 384, 83-87.
8. Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., and Lichtman, A. H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase, Proc. Natl. Acad. Sci. U.S.A. 98, 9371-9376.
9. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V., and Piomelli, D. (2003) Modulation of anxiety through blockade of anandamide hydrolysis, Nat. Med. 9, 76-81.
10. Lichtman, A. H., Shelton, C. C., Advani, T., and Cravatt, B. F. (2004) Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia, Pain 109, 319-327.
11. Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Walker, J. M., Holmes, P. V., Crystal, J. D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., and Piomelli, D. (2005) An endocannabinoid mechanism for stress-induced analgesia, Nature 435, 1108-1112.
12. Gobbi, G., Bambico, F. R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., Tontini, A., Taizia, G., Mor, M., Trezza, V., Goldberg, S. R., Cuomo, V., and Piomelli, D. (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis, Proc. Natl. Acad. Sci. U.S.A. 102, 18620-18625.
13. Huitron-Resendiz, S., Sanchez-Alavez, M., Wills, D. N., Cravatt, B. F., and Henriksen, S. J. (2004) Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase, Sleep 27, 857-865.
14. Cravatt, B. F., Saghatelian, A., Hawkins, E. G., Clement, A. B., Bracey, M. H., and Lichtman, A. H. (2004) Functional disassociation of the central and peripheral fatty acid amide signaling systems, Proc. Natl. Acad. Sci. U.S.A. 101, 10821-10826.
15. Holt, S., Comelli, F., Costa, B., and Fowler, C. J. (2005) Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors, Br. J. Pharmacol. 146, 467-476.
16. Cravatt, B. F., and Lichtman, A. H. (2003) Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system, Curr. Opin. Chem. Biol. 7, 469-475.
17. Saghatelian, A., Trauger, S. A., Want, E. J., Hawkins, E. G., Siuzdak, G., and Cravatt, B. F. (2004) Assignment of endogenous substrates to enzymes by global metabolite profiling, Biochemistry 43, 14332-14339.
18. Saghatelian, A., and Cravatt, B. F. (2005) Global strategies to integrate the proteome and metabolome, Curr. Opin. Chem. Biol. 9, 62-68.
19. Smith, C. A., Want, E. J., O'Maille, G., Abagyan, R., and Siuzdak, G. (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification, Anal. Chem. 78, 779-787.
20. Clement, A. C., Hawkins, E. G., Lichtman, A. H., and Cravatt, B. F. (2003) Increased seizure susceptibility and pro-convulsant activity of anandamide in mice lacking fatty acid amide hydrolase, J. Neurosci. 23, 3916-3923.
21. Bandell, M., Dubin, A. E., Petrus, M. J., Orth, A., Mathur, J., Hwang, S. W., and Patapoutian, A. (2006) High-throughput random mutagenesis screen reveals TRPM8 residues specifically required for activation by menthol, Nat. Neurosci. 9, 493-500.
22. Shonsey, E. M., Sfakianos, M., Johnson, M., He, D., Falany, C. N., Falany, J., Merkler, D. J., and Barnes, S. (2005) Bile acid coenzyme A: amino acid N-acyltransferase in the amino acid conjugation of bile acids, Methods Enzymol. 400, 374-394.
23. Chawla, A., Repa, J. J., Evans, R. M., and Mangelsdorf, D. J. (2001) Nuclear receptors and lipid physiology: opening the X-files, Science 294, 1866-1870.
24. Benham, C. D., Davis, J. B., and Randall, A. D. (2002) Vanilloid and TRP channels: a family of lipid-gated cation channels, Neuropharmacology 42, 873-888.
25. Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodriguez De Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., and Piomelli, D. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha, Nature 425, 90-93.
26. Van Der Stelt, M., and Di Marzo, V. (2004) Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels, Eur. J. Biochem. 271, 1827-1834.
27. Ross, R. A. (2003) Anandamide and vanilloid TRPV1 receptors, Br. J. Phamacol. 140, 790-801.
28. Tipton, K. F., Boyce, S., O'Sullivan, J., Davey, G. P., and Healy, J. (2004) Monoamine oxidases: certainties and uncertainties, Curr. Med. Chem. 11, 1965-1982.
29. Bari, M., Battista, N., Fezza, F., Gasperi, V., and Maccarrone, M. (2006) New insights into endocannabinoid degradation and its therapeutic potential, Mini-Rev. Med. Chem. 6, 257-268.
30. Falany, C. N., Fortinberry, H., Leiter, E. H., and Barnes, S. (1997) Cloning, expression, and chromosomal localization of mouse liver bile acid CoA:amino acid N-acyltransferase, J. Lipid Res. 38, 1139-1148.
31. O'Byrne, J., Hunt, M. C., Rai, D. K., Saeki, M., and Alexson, S. E. (2003) The human bile acid-CoA:amino acid N-acyltransferase functions in the conjugation of fatty acids to glycine, J. Biol. Chem. 278, 34237-34244.
32. Liedtke, W., Choe, Y., Marti-Renom, M. A., Bell, A. M., Denis, C. S., Sali, A., Hudspeth, A. J., Friedman, J. M., and Heller, S. (2000) Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor, Cell 103, 525-535.
33. Wang, Y., and Wang, D. H. (2006) A novel mechanism contributing to development of Dahl salt-sensitive hypertension: role of the transient receptor potential vanilloid type 1, Hypertension 47, 609-614.
34. Batkai, S., Pacher, P., Osei-Hyiaman, D., Radaeva, S., Liu, J., Harvey-White, J., Offertaler, K., Mackie, K., Rudd, M. A., Bukoski, R. D., and Kunos, G. (2004) Endocannabinoids acting at CB1 receptors regulate cardiovascular function in hypertension, Circulation 110, 1996-2002.
35. Kozak, K. R., Crews, B. C., Morrow, J. D., Wang, L. H., Ma, Y. H., Weinander, R., Jakobsson, P. J., and Marnett, L. J. (2002)
36. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides, J. Biol. Chem. 277, 44877-44885.
37. Kozak, K. R., Gupta, R. A., Moody, J. S., Ji, C., Boeglin, W. E., DuBois, R. N., Brash, A. R., and Marnett, L. J. (2002) 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist, J. Biol. Chem. 277, 23278-23286.
38. McKinney, M. K., and Cravatt, B. F. (2006) Structure-based design of a FAAH variant that discriminates between the N-acyl ethanolamine and taurine families of signaling lipids, Biochemistry, 45, 9016-9022.